A new study shows that aberrant DNA transposase activity promotes structural alterations that are clonally selected to drive tumor development. This discovery uncovers novel mechanisms of tumor-suppressor gene inactivation and highlights a new approach to cancer gene identification.
CITATION STYLE
Mack, S. C., Suzuki, H., & Taylor, M. D. (2017). Transposase-driven rearrangements in human tumors. Nature Genetics, 49(7), 975–977. https://doi.org/10.1038/ng.3908
Mendeley helps you to discover research relevant for your work.